These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 27300767

  • 21. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
    Chung RH, Chiu YF, Wang WC, Hwu CM, Hung YJ, Lee IT, Chuang LM, Quertermous T, Rotter JI, Chen YI, Chang IS, Hsiung CA.
    Diabetologia; 2021 Jul; 64(7):1613-1625. PubMed ID: 33842983
    [Abstract] [Full Text] [Related]

  • 22. Identification of structural motifs critical for human G6PC2 function informed by sequence analysis and an AlphaFold2-predicted model.
    Hawes EM, Claxton DP, Oeser JK, O'Brien RM.
    Biosci Rep; 2024 Jan 31; 44(1):. PubMed ID: 38095063
    [Abstract] [Full Text] [Related]

  • 23. Mutations in G6PC2 gene with increased risk for development of type 2 diabetes: Understanding via computational approach.
    Udhaya Kumar S, Kamaraj B, Varghese RP, Preethi VA, Bithia R, George Priya Doss C.
    Adv Protein Chem Struct Biol; 2022 Jan 31; 130():351-373. PubMed ID: 35534112
    [Abstract] [Full Text] [Related]

  • 24. A polymorphism within the G6PC2 gene is associated with fasting plasma glucose levels.
    Bouatia-Naji N, Rocheleau G, Van Lommel L, Lemaire K, Schuit F, Cavalcanti-Proença C, Marchand M, Hartikainen AL, Sovio U, De Graeve F, Rung J, Vaxillaire M, Tichet J, Marre M, Balkau B, Weill J, Elliott P, Jarvelin MR, Meyre D, Polychronakos C, Dina C, Sladek R, Froguel P.
    Science; 2008 May 23; 320(5879):1085-8. PubMed ID: 18451265
    [Abstract] [Full Text] [Related]

  • 25. A single-nucleotide polymorphism in a methylatable Foxa2 binding site of the G6PC2 promoter is associated with insulin secretion in vivo and increased promoter activity in vitro.
    Dos Santos C, Bougnères P, Fradin D.
    Diabetes; 2009 Feb 23; 58(2):489-92. PubMed ID: 18984742
    [Abstract] [Full Text] [Related]

  • 26. Biochemical and metabolic characterization of a G6PC2 inhibitor.
    Hawes EM, Rahim M, Haratipour Z, Orun AR, O'Rourke ML, Oeser JK, Kim K, Claxton DP, Blind RD, Young JD, O'Brien RM.
    Biochimie; 2024 Jul 23; 222():109-122. PubMed ID: 38431189
    [Abstract] [Full Text] [Related]

  • 27. Deletion of the gene encoding the islet-specific glucose-6-phosphatase catalytic subunit-related protein autoantigen results in a mild metabolic phenotype.
    Wang Y, Martin CC, Oeser JK, Sarkar S, McGuinness OP, Hutton JC, O'Brien RM.
    Diabetologia; 2007 Apr 23; 50(4):774-8. PubMed ID: 17265032
    [Abstract] [Full Text] [Related]

  • 28. A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.
    Hu C, Zhang R, Wang C, Ma X, Wang C, Fang Q, Bao Y, Xiang K, Jia W.
    Diabetologia; 2009 Mar 23; 52(3):451-6. PubMed ID: 19082990
    [Abstract] [Full Text] [Related]

  • 29. G6PC1 and G6PC2 influence G6P flux but not HSD11B1 activity.
    Hawes EM, Boortz KA, Oeser JK, O'Rourke ML, O'Brien RM.
    J Mol Endocrinol; 2023 Nov 01; 71(4):. PubMed ID: 37855366
    [Abstract] [Full Text] [Related]

  • 30. Daily Fasting Blood Glucose Rhythm in Male Mice: A Role of the Circadian Clock in the Liver.
    Ando H, Ushijima K, Shimba S, Fujimura A.
    Endocrinology; 2016 Feb 01; 157(2):463-9. PubMed ID: 26653333
    [Abstract] [Full Text] [Related]

  • 31. Alternative splicing of G6PC2, the gene coding for the islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP), results in differential expression in human thymus and spleen compared with pancreas.
    Dogra RS, Vaidyanathan P, Prabakar KR, Marshall KE, Hutton JC, Pugliese A.
    Diabetologia; 2006 May 01; 49(5):953-7. PubMed ID: 16520917
    [Abstract] [Full Text] [Related]

  • 32. Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.
    Chen WM, Erdos MR, Jackson AU, Saxena R, Sanna S, Silver KD, Timpson NJ, Hansen T, Orrù M, Grazia Piras M, Bonnycastle LL, Willer CJ, Lyssenko V, Shen H, Kuusisto J, Ebrahim S, Sestu N, Duren WL, Spada MC, Stringham HM, Scott LJ, Olla N, Swift AJ, Najjar S, Mitchell BD, Lawlor DA, Smith GD, Ben-Shlomo Y, Andersen G, Borch-Johnsen K, Jørgensen T, Saramies J, Valle TT, Buchanan TA, Shuldiner AR, Lakatta E, Bergman RN, Uda M, Tuomilehto J, Pedersen O, Cao A, Groop L, Mohlke KL, Laakso M, Schlessinger D, Collins FS, Altshuler D, Abecasis GR, Boehnke M, Scuteri A, Watanabe RM.
    J Clin Invest; 2008 Jul 01; 118(7):2620-8. PubMed ID: 18521185
    [Abstract] [Full Text] [Related]

  • 33. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.
    Mahajan A, Sim X, Ng HJ, Manning A, Rivas MA, Highland HM, Locke AE, Grarup N, Im HK, Cingolani P, Flannick J, Fontanillas P, Fuchsberger C, Gaulton KJ, Teslovich TM, Rayner NW, Robertson NR, Beer NL, Rundle JK, Bork-Jensen J, Ladenvall C, Blancher C, Buck D, Buck G, Burtt NP, Gabriel S, Gjesing AP, Groves CJ, Hollensted M, Huyghe JR, Jackson AU, Jun G, Justesen JM, Mangino M, Murphy J, Neville M, Onofrio R, Small KS, Stringham HM, Syvänen AC, Trakalo J, Abecasis G, Bell GI, Blangero J, Cox NJ, Duggirala R, Hanis CL, Seielstad M, Wilson JG, Christensen C, Brandslund I, Rauramaa R, Surdulescu GL, Doney AS, Lannfelt L, Linneberg A, Isomaa B, Tuomi T, Jørgensen ME, Jørgensen T, Kuusisto J, Uusitupa M, Salomaa V, Spector TD, Morris AD, Palmer CN, Collins FS, Mohlke KL, Bergman RN, Ingelsson E, Lind L, Tuomilehto J, Hansen T, Watanabe RM, Prokopenko I, Dupuis J, Karpe F, Groop L, Laakso M, Pedersen O, Florez JC, Morris AP, Altshuler D, Meigs JB, Boehnke M, McCarthy MI, Lindgren CM, Gloyn AL, T2D-GENES consortium and GoT2D consortium.
    PLoS Genet; 2015 Jan 01; 11(1):e1004876. PubMed ID: 25625282
    [Abstract] [Full Text] [Related]

  • 34. Association of a common G6PC2 variant with fasting plasma glucose levels in non-diabetic individuals.
    Demirci FY, Dressen AS, Hamman RF, Bunker CH, Kammerer CM, Kamboh MI.
    Ann Nutr Metab; 2010 Jan 01; 56(1):59-64. PubMed ID: 20029179
    [Abstract] [Full Text] [Related]

  • 35. Glucocorticoids stimulate hepatic and renal catecholamine inactivation by direct rapid induction of the dopamine sulfotransferase Sult1d1.
    Wong S, Tan K, Carey KT, Fukushima A, Tiganis T, Cole TJ.
    Endocrinology; 2010 Jan 01; 151(1):185-94. PubMed ID: 19966186
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Parenteral 17beta-estradiol decreases fasting blood glucose levels in non-obese mice with short-term ovariectomy.
    Kim JY, Jo KJ, Kim OS, Kim BJ, Kang DW, Lee KH, Baik HW, Han MS, Lee SK.
    Life Sci; 2010 Sep 11; 87(11-12):358-66. PubMed ID: 20655933
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.